Pollus (Suzhou) Biotechnology Co., Ltd is a new-type CRO that's dedicated to serving global pharmaceutical companies and research institutions. Its mission is to offer preclinical pharmacology and efficacy studies on non-human primate disease models with top-notch quality. It focuses on cardiovascular and cerebrovascular diseases, metabolic diseases in middle-aged and elderly people, and autoimmune diseases.

The company relies on well - known domestic and foreign universities and medical institutions. It has gathered a top - notch technical service team in the pre - clinical industry. Using professional scientific evaluation methods and high - quality animal resources, it connects innovative drugs from the gene, molecular, and cellular levels to the clinical stage. With the corporate values of high efficiency, high standards, and high quality (HiESQ), it empowers the pharmaceutical industry.